Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Bevacizumab in Combination With Everolimus and Erlotinib in Advanced Cancer

NCT00276575 is registered in ClinicalTrials.gov with Herbert Hurwitz, MD as lead sponsor.

NCT NCT00276575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Bevacizumab in Combination With Everolimus and Erlotinib in Advanced Cancer
Lead sponsor
Herbert Hurwitz, MD
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2005
Completion date
September 30, 2014
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific